These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 4900932)

  • 41. Clofibric and ethacrynic acids prevent experimental pyelonephritis by Escherichia coli in mice.
    Balagué CE; de Ruiz CS; Rey R; de Duffard AM; Nader-Macías ME
    FEMS Immunol Med Microbiol; 2004 Nov; 42(3):313-9. PubMed ID: 15477045
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Frequency of adherent colibacillus in a population with acute pyelonephritis and a population with acute cystitis].
    Monard A; Benoit G; Jacques L; Jardin A
    Prog Urol; 1993; 3(4):583-9. PubMed ID: 8104638
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Penicillin treatment and antibody response of pigs experimentally infected with Erysipelothrix insidiosa.
    Azechi H; Terakado N; Ninomiya K
    Am J Vet Res; 1972 Oct; 33(10):1963-73. PubMed ID: 5074700
    [No Abstract]   [Full Text] [Related]  

  • 44. Virulence of three types of Corynebacterium renale in cows.
    Hiramune T; Inui S; Murase N; Yanagawa R
    Am J Vet Res; 1971 Feb; 32(2):237-42. PubMed ID: 5545463
    [No Abstract]   [Full Text] [Related]  

  • 45. [Bases for the specific chemotherapy of chronic pyelonephritis].
    Mössner G; Gaca A; Thelen A; Schirmeister J; Maurer H
    Urologe; 1969; 8(1):2-9. PubMed ID: 4902333
    [No Abstract]   [Full Text] [Related]  

  • 46. EXPERIMENTAL PYELONEPHRITIS: A COMPARISON OF BLOOD-BORNE AND ASCENDING PATTERNS OF INFECTION.
    HEPTINSTALL RH
    J Pathol Bacteriol; 1965 Jan; 89():71-80. PubMed ID: 14263499
    [No Abstract]   [Full Text] [Related]  

  • 47. [Staphylococcal infection as a predisposing factor in experimental colipyelonephritis].
    Breunung M; Breunung MM; Peschel HG
    Padiatr Padol; 1971 Mar; 6(1):58-74. PubMed ID: 4949645
    [No Abstract]   [Full Text] [Related]  

  • 48. [Histological changes in the murine kidney in experimental hematogenic pyelonephritis from E. coli strains isolated from different sources].
    Bakŭrdzhiev T; Marinova R
    Eksp Med Morfol; 1981; 20(4):237-42. PubMed ID: 7035136
    [No Abstract]   [Full Text] [Related]  

  • 49. [Contribution of experimental pathology to the understanding of human pyelonephritis].
    Roberts JA
    Rev Prat; 1993 May; 43(9):1063-8. PubMed ID: 8378712
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Experimental pyelonephritis. I. Complement and antibody titer in non-obstructive enterococcal pyelonephritis].
    Tunn U; Brühl P
    Klin Wochenschr; 1969 May; 47(9):479-82. PubMed ID: 4986539
    [No Abstract]   [Full Text] [Related]  

  • 51. Experimental pyelonephritis: the influence of temporary and permanent ureteric obstruction on the localization of bacteria.
    BRUMFITT W; HEPTINSTALL RH
    Br J Exp Pathol; 1958 Dec; 39(6):610-7. PubMed ID: 13607919
    [No Abstract]   [Full Text] [Related]  

  • 52. [Method of creating a model of primary amicrobic chronic pyelonephritis].
    Pytel' IuA; Zolotarev II; Ufimtseva AG; Volkova VS; Tsomyk VG
    Patol Fiziol Eksp Ter; 1979; (2):49-51. PubMed ID: 450465
    [No Abstract]   [Full Text] [Related]  

  • 53. [Pyelonephritis].
    Kurokawa K
    Nihon Hinyokika Gakkai Zasshi; 1967 Sep; 58(9):927-31. PubMed ID: 4230496
    [No Abstract]   [Full Text] [Related]  

  • 54. BACTERICIDAL ANTIBODY TO ESCHERICHIA COLI IN GERM-FREE MICE.
    IKARI NS
    Nature; 1964 May; 202():879-81. PubMed ID: 14190078
    [No Abstract]   [Full Text] [Related]  

  • 55. [EXPERIMENTAL PYELONEPHRITIS].
    PRAT V; BENESHOVA D; DEIDAR R; GATALA M
    Urol Mosc; 1963; 28():11-5. PubMed ID: 14084914
    [No Abstract]   [Full Text] [Related]  

  • 56. Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
    Brooks SJ; Lyons JM; Braude AI
    Am J Pathol; 1974 Feb; 74(2):359-64. PubMed ID: 4590646
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Experimental haematogenous pyelonephritis in mice with uropathogenic, enteropathogenic and enterotoxigenic Escherichia coli.
    Kakar K; Sharma S; Asnani PJ; Banerjee CK; Sharma BK
    Antonie Van Leeuwenhoek; 1986; 52(2):153-61. PubMed ID: 3524448
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Immunologic parameters of children with urinary tract infection: effects of trimethoprim-sulfamethoxazole.
    Wolfish NM; Wassef N; Gonzalez H; Acharya C
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):76-9. PubMed ID: 1079471
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
    Kaijser B; Larsson P; Olling S
    Infect Immun; 1978 Apr; 20(1):78-81. PubMed ID: 352939
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Protective capacity of antibodies against Escherichia coli and K antigens.
    Kaijser B; Ahlstedt S
    Infect Immun; 1977 Aug; 17(2):286-9. PubMed ID: 70410
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.